Safety and Efficacy of CD19 UCAR-T Cells
1 clinical trials · Condition
◉ Watch Safety and Efficacy of CD19 UCAR-T Cells
| Record | Firm | Date |
|---|---|---|
| The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL) (NCT04166838) | Shanghai Longyao Biotechnology Inc., Ltd. | 2019-11-08 |
Track Safety and Efficacy of CD19 UCAR-T Cells automatically
Every clearance here is in the API, with alerts when new ones post.